Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Directors options

24th Nov 2008 09:51

RNS Number : 7543I
Oxford Catalysts Group PLC
24 November 2008
 

Oxford Catalysts Group PLC

(the "Company")

Grant of options to directors

Oxford Catalysts Group PLC announces that, further to the passing of resolution 4 at a general meeting of the Company held on 19 November 2008, the Company's remuneration committee met on the same day and agreed the following:

(i) Roy Lipski, Chief Executive Officer, was granted 600,000 options over ordinary shares of £0.01 each in the Company (“Ordinary Shares”) (representing approximately 1.0% of the current issued Ordinary Shares) at an exercise price of 1 pence per share pursuant to the Oxford Catalysts Group Share Option Scheme. Following this grant, Roy Lipski holds 2,004,370 options over Ordinary Shares (representing approximately 3.4% of the current issued Ordinary Shares); and
 
(ii) Susan Robertson, Chief Financial Officer, was granted 160,000 options over ordinary shares of £0.01 each in the Company (“Ordinary Shares”) (representing approximately 0.3% of the current issued Ordinary Shares) at an exercise price of 1 pence per share pursuant to the Oxford Catalysts Group Share Option Scheme. Following this grant, Susan Robertson holds 222,893 options over Ordinary Shares (representing approximately 0.4% of the current issued Ordinary Shares).

For more information, please contact:

Oxford Catalysts Group PLC
Pierre Jungels, Chairman
+44 (0)1235 841 700
Roy Lipski, Chief Executive Officer
 
 
 
KBC Peel Hunt Ltd (nominated adviser and broker )
Jonathan Marren
+44 (0)20 7418 8900
Oliver Stratton
 
 
 
Financial Dynamics Limited (financial public relations)
Billy Clegg
+44 (0)20 7831 3113
Alex Beagley
 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDGMZMLDLGRZG

Related Shares:

VLS.L
FTSE 100 Latest
Value8,607.98
Change22.97